B-CELL LYMPHOPROLIFERATIVE DISORDER
Clinical trials for B-CELL LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat blood cancer: experimental drug trial opens
Disease control Recruiting nowThis study is testing an oral drug called pacritinib for people with Waldenström macroglobulinemia, a rare blood cancer, that has come back or stopped responding to other treatments. The drug works by blocking specific proteins that help the cancer cells survive and grow. About 3…
Matched conditions: B-CELL LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Apr 04, 2026 01:50 UTC
-
New immune therapy trial offers hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing an experimental drug called epcoritamab in patients with Waldenstrom Macroglobulinemia, a rare blood cancer, who have already tried other treatments. The drug is a type of antibody designed to help the patient's own immune system find and attack cancer cells…
Matched conditions: B-CELL LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Gottfried von Keudell, MD PhD • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC